UK markets open in 3 hours 35 minutes
NIKKEI 225
38,299.71 +25.66 (+0.07%) HANG SENG
18,172.50 +409.47 (+2.31%) CRUDE OIL
79.43 +0.43 (+0.54%) GOLD FUTURES
2,328.30 +17.30 (+0.75%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,880.08 -1,998.05 (-4.17%)
Abbott Laboratories (ABT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 183.88B |
| Enterprise value | 192.23B |
| Trailing P/E | 33.01 |
| Forward P/E | 22.83 |
| PEG ratio (5-yr expected) | 5.78 |
| Price/sales (ttm) | 4.59 |
| Price/book (mrq) | 4.76 |
| Enterprise value/revenue | 4.77 |
| Enterprise value/EBITDA | 21.29 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.74 |
| 52-week change 3 | -4.12% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 121.64 |
| 52-week low 3 | 89.67 |
| 50-day moving average 3 | 113.16 |
| 200-day moving average 3 | 106.68 |
Share statistics
| Avg vol (3-month) 3 | 5.67M |
| Avg vol (10-day) 3 | 5.08M |
| Shares outstanding 5 | 1.74B |
| Implied shares outstanding 6 | 1.76B |
| Float 8 | 1.72B |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 76.82% |
| Shares short (15 Apr 2024) 4 | 12.94M |
| Short ratio (15 Apr 2024) 4 | 1.88 |
| Short % of float (15 Apr 2024) 4 | 0.75% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.75% |
| Shares short (prior month 15 Mar 2024) 4 | 15.72M |
Dividends & splits
| Forward annual dividend rate 4 | 2.2 |
| Forward annual dividend yield 4 | 2.08% |
| Trailing annual dividend rate 3 | 2.12 |
| Trailing annual dividend yield 3 | 2.00% |
| 5-year average dividend yield 4 | 1.60 |
| Payout ratio 4 | 64.80% |
| Dividend date 3 | 15 May 2024 |
| Ex-dividend date 4 | 12 Apr 2024 |
| Last split factor 2 | 10000:4798 |
| Last split date 3 | 02 Jan 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 13.96% |
| Operating margin (ttm) | 14.06% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 40.33B |
| Revenue per share (ttm) | 23.18 |
| Quarterly revenue growth (yoy) | 2.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 10.34B |
| Net income avi to common (ttm) | 5.61B |
| Diluted EPS (ttm) | 3.21 |
| Quarterly earnings growth (yoy) | -7.10% |
Balance sheet
| Total cash (mrq) | 7.28B |
| Total cash per share (mrq) | 4.2 |
| Total debt (mrq) | 15.87B |
| Total debt/equity (mrq) | 40.88% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 22.26 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.